Contineum Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Contineum Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2023 to Q3 2024.
  • Contineum Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $0.000.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $0 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $231K Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $474K Mar 31, 2024 10-Q 2024-05-16
Q4 2023 $719K Dec 31, 2023 10-Q 2024-11-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.